MDXG compared with BVS: revenue, margins and what each company keeps, and the suppliers and customers both name

MDXGMimedx Group, Inc.

Mkt capRevenueRevenue

BVSBioventus Inc.

Mkt capRevenueRevenue

Compare

MDXGMimedx Group, Inc.

BVSBioventus Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MDXG: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

MDXG, solidBVS, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MDXG 4

TTRXTurn Therapeuticssupplier

—Regenity Biosciencesunlistedsupplier

—Regen Lab USAunlistedsupplier

—Gunze Medicalunlistedcustomer

Shared 0

No shared counterparties.

Only BVS 1

—Apex Biologixunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MDXGMimedx Group, Inc.

3.88▼−2.22%· post 3.88

Mkt cap$566.2MRevenue$62MQ3 FY26Revenue$419MFY25

BVSBioventus Inc.

13.35▼−10.25%· post 13.28

ClosedOct 30 '26

Mkt cap$1.1BRevenue$153MQ2 FY26Revenue$568MFY25

Compare

ClosedOct 30 '26

MDXGMimedx Group, Inc.

BVSBioventus Inc.

3.88▼−2.22%post 3.88

Price

13.35▼−10.25%post 13.28

$566.2M

Mkt cap

$1.1B

Q3 FY26$62M

Revenue

$153MQ2 FY26

FY25$419M

Revenue

$568MFY25

MDXG3.88▼−2.22%vsBVS13.35▼−10.25%ClosedOct 30 '26